Recognizing the Differentiation Degree of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cells Using Machine Learning and Deep Learning-Based Approaches

Cells. 2023 Jan 4;12(2):211. doi: 10.3390/cells12020211.

Abstract

Induced pluripotent stem cells (iPSCs) can be differentiated into mesenchymal stem cells (iPSC-MSCs), retinal ganglion cells (iPSC-RGCs), and retinal pigmental epithelium cells (iPSC-RPEs) to meet the demand of regeneration medicine. Since the production of iPSCs and iPSC-derived cell lineages generally requires massive and time-consuming laboratory work, artificial intelligence (AI)-assisted approach that can facilitate the cell classification and recognize the cell differentiation degree is of critical demand. In this study, we propose the multi-slice tensor model, a modified convolutional neural network (CNN) designed to classify iPSC-derived cells and evaluate the differentiation efficiency of iPSC-RPEs. We removed the fully connected layers and projected the features using principle component analysis (PCA), and subsequently classified iPSC-RPEs according to various differentiation degree. With the assistance of the support vector machine (SVM), this model further showed capabilities to classify iPSCs, iPSC-MSCs, iPSC-RPEs, and iPSC-RGCs with an accuracy of 97.8%. In addition, the proposed model accurately recognized the differentiation of iPSC-RPEs and showed the potential to identify the candidate cells with ideal features and simultaneously exclude cells with immature/abnormal phenotypes. This rapid screening/classification system may facilitate the translation of iPSC-based technologies into clinical uses, such as cell transplantation therapy.

Keywords: artificial intelligence; convolutional neural network; deep learning; induced pluripotent stem cells; retinal pigment epithelial cells; traditional machine learning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Intelligence
  • Cell Differentiation
  • Deep Learning*
  • Humans
  • Induced Pluripotent Stem Cells*
  • Retinal Pigment Epithelium

Grants and funding

This study was funded by Ministry of Science and Technology (MOST) (MOST 111-2314-B-075-036-MY3; MOST 111-2320-B-075-007; MOST 111-2320-B-A49-028-MY3; MOST 111-2321-B-A49-009), National Science and Technology Council (NSTC 111-2634-F-006-012); Taipei Veterans General Hospital (V111B-025).